AU Patent

AU2021268204A1 — Novel compositions of matter and pharmaceutical compositions

Assigned to Psilera Inc · Expires 2022-12-08 · 3y expired

What this patent protects

Pharmaceutical formulations of novel indole compounds and psilocybin analogs are manufactured, provided in novel oral, transdermal, and nasal pharmaceutical compositions for use to treat neurological, mood or abuse diseases and disorders.

USPTO Abstract

Pharmaceutical formulations of novel indole compounds and psilocybin analogs are manufactured, provided in novel oral, transdermal, and nasal pharmaceutical compositions for use to treat neurological, mood or abuse diseases and disorders.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021268204A1
Jurisdiction
AU
Classification
—
Expires
2022-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Psilera Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.